Shopping Cart
Remove All
Your shopping cart is currently empty
BCMA/TNFRSF17 Protein, Human, Recombinant
(Synonyms: Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD_antigen: CD269, BCM, B-cell maturation protein) Copy Product InfoSynonyms: Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD_antigen: CD269, BCM, B-cell maturation protein
Catalog No. TMPS-00150 Copy Product Info
BCMA/TNFRSF17 Protein, Human, Recombinant is expressed in E. coli. The accession number is Q02223.
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 μg | $128 | 7-10 days | 7-10 days | |
| 10 μg | $213 | 7-10 days | 7-10 days | |
| 20 μg | $356 | 7-10 days | 7-10 days | |
| 50 μg | $735 | 7-10 days | 7-10 days | |
| 100 μg | $1,270 | 7-10 days | 7-10 days | |
| 200 μg | $2,220 | 7-10 days | 7-10 days | |
| 500 μg | $4,650 | 7-10 days | 7-10 days | |
| 1 mg | $8,130 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Bioactivity | Fully biologically active when compared to standard. The ED 50 as determined by its ability to inhibit APRIL-mediated proliferation of anti-IgM stimulated murine B cells is no less than 40.0 ng/ml, corresponding to a specific activity of > 2.5 × 10 4 IU/mg in the presence of 100.0 ng/ml human APRIL. |
| Description | BCMA/TNFRSF17 Protein, Human, Recombinant is expressed in E. coli. The accession number is Q02223. |
| Species | Human |
| Expression System | E. coli |
| Tag | Tag Free |
| Accession Number | Q02223 |
| Construction | Ala5-Ala54 |
| Protein Purity | > 98% as determined by SDS-PAGE; > 98% as determined by HPLC |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from a 0.2 μm filtered solution in 30% acetonitrile, 0.1% TFA. |
| Reconstitution | It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. |
| Stability & Storage | Upon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Shipping | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| Synonyms | Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD_antigen: CD269, BCM, B-cell maturation protein |
| Research Background |
| Molecular Weight | 5.4 kDa (Predicted) |
| Storage | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: BCMA/TNFRSF17 Protein, Human, Recombinant chemical structure | BCMA/TNFRSF17 Protein, Human, Recombinant molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.